Paeds SAQs · endocrinology-diabetes-and-growth
Congenital adrenal hyperplasia — formative SAQs
Two formative SAQs on congenital adrenal hyperplasia: the genitally normal male neonate who salt-wastes at two weeks, and the virilised 46,XX newborn, testing the salt-wasting crisis resuscitation, the 17-OHP work-up and lifelong replacement with stress dosing.
On this page
Study tools
Target exams
RACP General PaediatricsRACP DWEMRCPCH TheoryABP General Pediatrics
Prompt
Congenital adrenal hyperplasia
SAQ 1 — The two-week-old vomiting boy (20 marks, ~15 minutes)
A term male infant, genitally normal at birth, passed his newborn bloodspot screen. He presents at day 14 with three days of poor feeding and vomiting, and is now lethargic and mottled. Weight is down 12 percent from birth. Sodium 122 mmol per litre, potassium 6.8 mmol per litre, glucose 1.9 mmol per litre, capillary pH 7.24 with a base excess of minus 10. [8]
Questions
- Give the most likely diagnosis, the single most important immediate drug, and its dose and route. (5 marks) [4]
- Outline the first-hour resuscitation and investigation bundle, and state why the definitive test does not delay treatment. (5 marks) [4]
- Explain why the diagnosis was missed despite a passed newborn screen, and what that implies for the threshold to investigate a vomiting neonate. (4 marks) [8]
- Describe the lifelong replacement regimen and the stress-dose plan you will give the family. (6 marks) [1]
Model answer (must-hit)
- This is classic salt-wasting 21-hydroxylase deficiency until proven otherwise. A genitally normal male neonate who salt-wastes at one to three weeks — with hyponatraemia, hyperkalaemia, hypoglycaemia and acidosis — is the classic missed presentation. The immediate drug is hydrocortisone intravenously: 25 mg stat, then 50 to 100 mg per square metre per day. [4]
- Resuscitate on three tracks: 10 to 20 mL per kg isotonic saline repeated to restore perfusion; hydrocortisone as above; treat the hypoglycaemia with intravenous dextrose and cover sepsis with cultures and empiric antibiotics. Send serum 17-hydroxyprogesterone, ACTH, plasma renin, aldosterone and androgens, a karyotype and a pelvic ultrasound, and CYP21A2 molecular testing. The definitive biochemistry confirms the diagnosis but does not treat the shock, so hydrocortisone is given empirically before the results return. [4]
- The newborn 17-hydroxyprogesterone screen is sensitive but imperfect: it misses a minority of classic cases, over-represented by simple-virilising disease and infants whose salt-wasting declares after the screen. A passed screen never lowers the threshold to send a serum 17-hydroxyprogesterone in any vomiting or collapsing neonate. [8]
- Start oral hydrocortisone 10 to 15 mg per square metre per day in three divided doses, add fludrocortisone 0.05 to 0.2 mg per day, and supplement oral sodium at 2 to 3 mmol per kg per day in infancy. Build a stress-dose plan: two to three times the hydrocortisone dose for illness, and a parent-held intramuscular hydrocortisone injection for vomiting or collapse, with a MedicAlert identifier and a school care plan. [1]
References6ShowHide
- [1]Speiser PW; Azziz R; Baskin LS; et al Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2010.PMID 20823466
- [4]Bornstein SR; Allolio B; Arlt W; et al Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2016.PMID 26760044
- [5]Gidlöf S; Wedell A; Guthenberg C; et al Nationwide neonatal screening for congenital adrenal hyperplasia in Sweden: a 26-year longitudinal prospective population-based study. JAMA Pediatr, 2014.PMID 24733564
- [8]Sarafoglou K; Banks K; Kyllo C; et al Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota. JAMA, 2012.PMID 22692165
- [9]New MI; Abraham M; Gonzalez B; et al Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A, 2013.PMID 23359698
- [10]Houk CP; Hughes IA; Ahmed SF; et al Summary of consensus statement on intersex disorders and their management. Pediatrics, 2006.PMID 16882833